Multifunctional 3D-Printed Wound Dressings Containing a Combination of Synergistic Antimicrobials in the Management

Iman Mattar1,2,3, Guillermo Landa1,2,3, Marina Frutos-Lizano2,3

  • 1Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, 50009 Zaragoza, Spain.

PubMed

Insights

Advanced 3D printed wound dressings combine octenidine (OCT) and lysostaphin (LYS) to effectively combat methicillin-resistant Staphylococcus aureus (MRSA) infections. These novel dressings demonstrate potent antimicrobial and anti-inflammatory properties, promoting faster wound healing.

Area of Science:

  • Biomaterials Engineering
  • Antimicrobial Therapeutics
  • Wound Healing Research

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat to surgical wound healing.
  • Existing wound care strategies struggle to effectively manage MRSA colonization in acute and chronic wounds.
  • Novel antimicrobial delivery systems are needed to overcome MRSA resistance and promote healing.

Purpose of the Study:

  • To develop advanced, 3D-printed wound dressings incorporating antimicrobial agents for MRSA eradication.
  • To investigate the synergistic antimicrobial and anti-inflammatory effects of combining octenidine (OCT) and lysostaphin (LYS).
  • To evaluate the efficacy of these novel dressings in preclinical wound models.

Main Methods:

  • Fused deposition modeling was used to 3D print wound dressings loaded with OCT.
  • Lysostaphin (LYS) was surface-functionalized onto OCT-loaded dressings via supramolecular interactions.
  • Antimicrobial activity (MIC, MBC, eradication assays), synergistic effects (FICI), and anti-inflammatory properties (NO production, gene expression) were assessed.
  • Preclinical models were used to evaluate in vivo therapeutic effects.

Main Results:

  • The OCT-LYS combination exhibited significant synergy against MRSA (FICI = 0.156).
  • The dressings completely eradicated MRSA USA 300 inocula (10^5 CFU/mL) within 96 hours.
  • OCT demonstrated potent anti-inflammatory effects by reducing NO production and pro-inflammatory gene expression.
  • OCT-LYS dressings showed superior in vivo therapeutic outcomes compared to individual components.

Conclusions:

  • 3D-printed OCT-LYS wound dressings offer a promising dual-action approach against MRSA infections.
  • These dressings effectively reduce bacterial burden and inflammation, facilitating accelerated wound healing.
  • The synergistic combination of OCT and LYS represents a significant advancement in antimicrobial wound care.